CNS Pharmaceuticals (CNSP) Competitors $1.10 -0.03 (-2.65%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$1.09 -0.01 (-0.91%) As of 04/4/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CNSP vs. SYBX, LPTX, NRSN, IXHL, AFMD, MRKR, SPRB, MTVA, HCWB, and IPAShould you be buying CNS Pharmaceuticals stock or one of its competitors? The main competitors of CNS Pharmaceuticals include Synlogic (SYBX), Leap Therapeutics (LPTX), NeuroSense Therapeutics (NRSN), Incannex Healthcare (IXHL), Affimed (AFMD), Marker Therapeutics (MRKR), Spruce Biosciences (SPRB), MetaVia (MTVA), HCW Biologics (HCWB), and ImmunoPrecise Antibodies (IPA). These companies are all part of the "pharmaceutical products" industry. CNS Pharmaceuticals vs. Synlogic Leap Therapeutics NeuroSense Therapeutics Incannex Healthcare Affimed Marker Therapeutics Spruce Biosciences MetaVia HCW Biologics ImmunoPrecise Antibodies CNS Pharmaceuticals (NASDAQ:CNSP) and Synlogic (NASDAQ:SYBX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability, earnings, media sentiment and community ranking. Which has more risk & volatility, CNSP or SYBX? CNS Pharmaceuticals has a beta of 2.72, indicating that its stock price is 172% more volatile than the S&P 500. Comparatively, Synlogic has a beta of 0.69, indicating that its stock price is 31% less volatile than the S&P 500. Does the media prefer CNSP or SYBX? In the previous week, CNS Pharmaceuticals had 2 more articles in the media than Synlogic. MarketBeat recorded 2 mentions for CNS Pharmaceuticals and 0 mentions for Synlogic. CNS Pharmaceuticals' average media sentiment score of 0.00 equaled Synlogic'saverage media sentiment score. Company Overall Sentiment CNS Pharmaceuticals Neutral Synlogic Neutral Which has higher valuation & earnings, CNSP or SYBX? CNS Pharmaceuticals has higher earnings, but lower revenue than Synlogic. Synlogic is trading at a lower price-to-earnings ratio than CNS Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCNS PharmaceuticalsN/AN/A-$18.85M-$3.75 thousand0.00Synlogic$8K1,578.96-$57.28M-$2.51-0.43 Is CNSP or SYBX more profitable? CNS Pharmaceuticals' return on equity of 0.00% beat Synlogic's return on equity.Company Net Margins Return on Equity Return on Assets CNS PharmaceuticalsN/A N/A -515.32% Synlogic N/A -207.84%-114.81% Do analysts rate CNSP or SYBX? CNS Pharmaceuticals presently has a consensus price target of $25.00, suggesting a potential upside of 2,172.73%. Given CNS Pharmaceuticals' stronger consensus rating and higher possible upside, research analysts clearly believe CNS Pharmaceuticals is more favorable than Synlogic.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CNS Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 3.00Synlogic 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals hold more shares of CNSP or SYBX? 14.0% of CNS Pharmaceuticals shares are held by institutional investors. Comparatively, 63.4% of Synlogic shares are held by institutional investors. 0.1% of CNS Pharmaceuticals shares are held by company insiders. Comparatively, 3.0% of Synlogic shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in CNSP or SYBX? Synlogic received 283 more outperform votes than CNS Pharmaceuticals when rated by MarketBeat users. However, 70.59% of users gave CNS Pharmaceuticals an outperform vote while only 69.54% of users gave Synlogic an outperform vote. CompanyUnderperformOutperformCNS PharmaceuticalsOutperform Votes4870.59% Underperform Votes2029.41% SynlogicOutperform Votes33169.54% Underperform Votes14530.46% SummaryCNS Pharmaceuticals beats Synlogic on 9 of the 15 factors compared between the two stocks. Remove Ads Get CNS Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CNSP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNSP vs. The Competition Export to ExcelMetricCNS PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.24M$6.32B$5.24B$7.07BDividend YieldN/A2.85%4.87%4.05%P/E Ratio-0.016.7221.1817.48Price / SalesN/A186.91356.3585.27Price / CashN/A65.6738.1634.64Price / Book-0.035.576.233.79Net Income-$18.85M$141.67M$3.20B$247.10M7 Day Performance-15.38%-11.44%-8.32%-7.32%1 Month Performance-51.33%-14.59%-3.36%-10.19%1 Year Performance-99.84%-18.30%2.72%-7.41% CNS Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNSPCNS Pharmaceuticals1.2866 of 5 stars$1.10-2.7%$25.00+2,172.7%-99.8%$3.24MN/A-0.015Upcoming EarningsGap UpSYBXSynlogicN/A$1.29-0.7%N/A-39.7%$15.10M$8,000.00-0.3180Gap DownLPTXLeap Therapeutics2.1559 of 5 stars$0.39-2.7%$4.92+1,160.7%-89.4%$14.94MN/A-0.2040Short Interest ↓Gap DownNRSNNeuroSense Therapeutics0.3197 of 5 stars$1.08+0.9%N/A-51.9%$14.76MN/A-1.6910News CoverageGap DownIXHLIncannex Healthcare0.3335 of 5 stars$0.80-3.5%N/A-85.1%$14.29M$98,000.00-0.583News CoveragePositive NewsGap UpAFMDAffimed4.2104 of 5 stars$0.87-1.8%$13.50+1,448.2%-91.3%$14.04M$877,000.000.00200Analyst ForecastShort Interest ↓News CoverageGap UpMRKRMarker Therapeutics3.909 of 5 stars$1.28+2.4%$13.50+954.7%-79.3%$13.71M$3.31M0.0060Earnings ReportAnalyst ForecastAnalyst RevisionGap DownSPRBSpruce Biosciences2.4282 of 5 stars$0.33-2.0%$2.50+657.8%-66.6%$13.63M$7.10M-0.3520News CoverageGap UpMTVAMetaVia1.9912 of 5 stars$1.58+1.9%$12.00+659.5%N/A$13.61MN/A0.0010Analyst RevisionNews CoverageGap UpHCWBHCW Biologics1.101 of 5 stars$0.30-1.2%N/A-85.6%$13.36M$3.50M-0.3040Earnings ReportUpcoming EarningsStock SplitNews CoverageGap UpIPAImmunoPrecise Antibodies1.7836 of 5 stars$0.43+1.6%$5.00+1,062.8%-75.2%$13.36M$24.07M-0.5580Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage Remove Ads Related Companies and Tools Related Companies SYBX Competitors LPTX Competitors NRSN Competitors IXHL Competitors AFMD Competitors MRKR Competitors SPRB Competitors MTVA Competitors HCWB Competitors IPA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CNSP) was last updated on 4/5/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIt’s Time to Buy Elon’s “ChatGPT Killer”Elon Musk’s new AI model is blowing everyone’s mind. It has been called “a game-changer in AI innovation”.....Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CNS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CNS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CNSP Stock Free CNSP Stock Alerts